Doug Schenkel
Stock Analyst at Wolfe Research
(3.62)
# 762
Out of 4,893 analysts
66
Total ratings
54.17%
Success rate
34.72%
Average return
Main Sectors:
Stocks Rated by Doug Schenkel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TEM Tempus AI | Initiates: Outperform | $60 | $59.60 | +0.67% | 1 | Dec 13, 2024 | |
| HOLX Hologic | Initiates: Peer Perform | n/a | $66.85 | - | 5 | Dec 13, 2024 | |
| TWST Twist Bioscience | Initiates: Outperform | $60 | $38.47 | +55.97% | 2 | Dec 13, 2024 | |
| STVN Stevanato Group | Initiates: Outperform | $28 | $25.94 | +7.94% | 1 | Dec 13, 2024 | |
| WST West Pharmaceutical Services | Initiates: Peer Perform | n/a | $229.23 | - | 1 | Dec 13, 2024 | |
| RGEN Repligen | Initiates: Peer Perform | n/a | $134.00 | - | 1 | Nov 14, 2024 | |
| MRVI Maravai LifeSciences Holdings | Initiates: Peer Perform | n/a | $2.89 | - | 1 | Nov 14, 2024 | |
| DHR Danaher | Upgrades: Outperform | $285 | $205.51 | +38.68% | 2 | Oct 31, 2024 | |
| BRKR Bruker | Downgrades: Peer Perform | n/a | $43.58 | - | 2 | Sep 30, 2024 | |
| A Agilent Technologies | Downgrades: Peer Perform | n/a | $124.17 | - | 8 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $52 | $48.55 | +6.08% | 2 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $12.62 | - | 3 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $100.05 | - | 5 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $53.32 | - | 4 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $430.73 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $5.50 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $102.40 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $1.50 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $13.70 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $51.29 | - | 2 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $163.36 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $353.28 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $3.74 | - | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $2.73 | - | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $2.75 | - | 1 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $7.22 | - | 1 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $2.18 | - | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $3.94 | - | 1 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $18 | $3.11 | +478.78% | 1 | Jun 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $16.17 | - | 2 | Mar 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $90 | $297.40 | -69.74% | 2 | Feb 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $5.86 | - | 1 | Jan 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $221.26 | - | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $16 | $85.46 | -81.28% | 2 | Sep 28, 2017 |
Tempus AI
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $59.60
Upside: +0.67%
Hologic
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $66.85
Upside: -
Twist Bioscience
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $38.47
Upside: +55.97%
Stevanato Group
Dec 13, 2024
Initiates: Outperform
Price Target: $28
Current: $25.94
Upside: +7.94%
West Pharmaceutical Services
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $229.23
Upside: -
Repligen
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $134.00
Upside: -
Maravai LifeSciences Holdings
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $2.89
Upside: -
Danaher
Oct 31, 2024
Upgrades: Outperform
Price Target: $285
Current: $205.51
Upside: +38.68%
Bruker
Sep 30, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $43.58
Upside: -
Agilent Technologies
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $124.17
Upside: -
Jun 27, 2024
Upgrades: Outperform
Price Target: $52
Current: $48.55
Upside: +6.08%
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $12.62
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $100.05
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $53.32
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $430.73
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $5.50
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $102.40
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $1.50
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $13.70
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $51.29
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $163.36
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $353.28
Upside: -
Aug 17, 2021
Initiates: Outperform
Price Target: n/a
Current: $3.74
Upside: -
Aug 16, 2021
Initiates: Market Perform
Price Target: n/a
Current: $2.73
Upside: -
Aug 9, 2021
Initiates: Outperform
Price Target: n/a
Current: $2.75
Upside: -
Jan 12, 2021
Initiates: Outperform
Price Target: n/a
Current: $7.22
Upside: -
Dec 29, 2020
Initiates: Outperform
Price Target: n/a
Current: $2.18
Upside: -
Jul 7, 2020
Initiates: Outperform
Price Target: n/a
Current: $3.94
Upside: -
Jun 19, 2018
Initiates: Outperform
Price Target: $18
Current: $3.11
Upside: +478.78%
Mar 28, 2018
Upgrades: Outperform
Price Target: n/a
Current: $16.17
Upside: -
Feb 22, 2018
Maintains: Outperform
Price Target: $80 → $90
Current: $297.40
Upside: -69.74%
Jan 2, 2018
Initiates: Outperform
Price Target: n/a
Current: $5.86
Upside: -
Nov 1, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $221.26
Upside: -
Sep 28, 2017
Maintains: Outperform
Price Target: $23 → $16
Current: $85.46
Upside: -81.28%